[Role of lipid-modifying components of biomembranes in antipancreatic effect of metabolic drugs].
The high effectiveness of metabolic medication in acute pancreatitis therapy was demonstrated by experimental and clinical researches. The medication capability for knocking-over of systemic lipid distress-syndrome determines its membraneprotective effect, which promotes correction of functional disorders of different organs cell structures and decrease of intoxication syndrome. The expressed lipid corrective effect of metabolic therapy determines major pathogenesis component of its high clinical effectiveness under acute pancreatitis, that confirms important role of lipid modificated component of cell structures membrane by metabolic therapy in knocking-over of acute pancreas inflammation.